학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 104건 | 목록 1~10
Palafox M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Monserrat L; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Bellet M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Villacampa G; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Gonzalez-Perez A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Oliveira M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Ibrahimi N; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.; Oncostat U1018, Inserm, University Paris-Saclay, Villejuif, France.; Kannan S; Bioinformatics Institute (ASTAR), Singapore, Singapore.; Mina L; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Herrera-Abreu MT; The Breast Cancer Now Research Centre, London, UK.; Òdena A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Capelán M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Azaro A; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Bruna A; Preclinical Modelling of Pediatric Cancer Evolution Group, The Institute of Cancer Research, London, UK.; Rodríguez O; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Guzmán M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Viaplana C; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Hernández J; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.; Su F; Novartis Pharmaceuticals, East Hanover, NJ, USA.; Lin K; Genentech, Inc., South San Francisco, California, USA.; Clarke RB; Breast Biology Group, Manchester Breast Centre, Manchester, UK.; Caldas C; Cancer Research UK, Cambridge, UK.; Arribas J; CIBERONC, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Growth Factors Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.; Oncostat U1018, Inserm, University Paris-Saclay, Villejuif, France.; García-Sanz A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Turner NC; The Breast Cancer Now Research Centre, London, UK.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Department of Oncology, IOB Institute of Oncology, Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Dienstmann R; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Verma CS; Bioinformatics Institute (ASTAR), Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.; Lopez-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Scaltriti M; Departments of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA.; Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Inserm Unit U981, Villejuif, France.; Saura C; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.; CIBERONC, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Palafox M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Monserrat L; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Bellet M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Villacampa G; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Gonzalez-Perez A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Oliveira M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Ibrahimi N; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.; Oncostat U1018, Inserm, University Paris-Saclay, Villejuif, France.; Kannan S; Bioinformatics Institute (ASTAR), Singapore, Singapore.; Mina L; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Herrera-Abreu MT; The Breast Cancer Now Research Centre, London, UK.; Òdena A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Capelán M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Azaro A; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Bruna A; Preclinical Modelling of Pediatric Cancer Evolution Group, The Institute of Cancer Research, London, UK.; Rodríguez O; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Guzmán M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Viaplana C; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Hernández J; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.; Su F; Novartis Pharmaceuticals, East Hanover, NJ, USA.; Lin K; Genentech, Inc., South San Francisco, California, USA.; Clarke RB; Breast Biology Group, Manchester Breast Centre, Manchester, UK.; Caldas C; Cancer Research UK, Cambridge, UK.; Arribas J; CIBERONC, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Growth Factors Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.; Oncostat U1018, Inserm, University Paris-Saclay, Villejuif, France.; García-Sanz A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Turner NC; The Breast Cancer Now Research Centre, London, UK.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Department of Oncology, IOB Institute of Oncology, Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Dienstmann R; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Verma CS; Bioinformatics Institute (ASTAR), Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.; Lopez-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Scaltriti M; Departments of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA.; Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Inserm Unit U981, Villejuif, France.; Saura C; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.; CIBERONC, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
In: Anuario Colombiano de Historia Social y de la Cultura. (Anuario Colombiano de Historia Social y de la Cultura, January 2023, 50(1):291-317)
검색 결과 제한하기
제한된 항목
[검색어] Capelán, M.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어